Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-04-07

Clinical Trial Update: Costs, Quality of Life and Functional Outcomes in Veterans Treated for Multiple Sclerosis With Beta-Interferon l-B (Betaseron)

View source ↗

Summary

This completed clinical trial update reports on costs, quality of life, and functional outcomes in veterans with multiple sclerosis treated with interferon beta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Betaseron (Interferon beta-1b)

Snippet

Sponsor: US Department of Veterans Affairs | Conditions: Multiple Sclerosis | Status: COMPLETED